Adverse birth outcomes are more experienced by pregnant women with acute migraine
Acute migraine attacks in pregnant women are very serious and debilitating which leads to many complications during delivery such as preeclampsia, low birthweight and preterm delivery and need emergency care. Such adverse events were seven times more which were seen in the age of 35 or more. Montefiore Health System are responsible to conduct these findings and at the American Academy of Neurology's 68th Annual Meeting, these findings will be presented on April 15 to 21, 2016.
According to Matthew S. Robbins, M.D., director of inpatient services at Montefiore Headache Center, chief of neurology at Jack D. Weiler Hospital of Montefiore, and associate professor of clinical neurology at Albert Einstein College of Medicine, "The results of this study were of particular interest because more than half of the pregnant women with migraine experienced some type of adverse birth outcome, suggesting that these pregnancies should be considered high risk,". "These findings need to be replicated with a larger number of women, including those who have migraine that does not manifest with severe attacks during pregnancy."
Nausea, vomiting, light and sound sensitivity and visual disturbances are the symptoms of acute migraine attacks. At Montefiore, investigators analyzed the data of 5 years and found that 90 pregnant women with severe migraine are in exigency of care. The findings included:
54% of women had at least one complication.
A preterm delivery is identified in nearly 30% of women in comparison to almost 10% in the normal population.
20% of women with migraine had preeclampsia in comparison between 5 and 8% in the normal population.
Low birthweight noticed in newly born babies by 19% of women who had migraine as compared to 8% in general population.
62% of women with migraine were administered with pill and intravenous drugs combination. Of those, 76% were given acetaminophen, while 54% took intravenous (IV) metoclopramide (a drug also advised for nausea) and 54% of women were given diphenhydramine intravenously which is an antihistamine. However, it is not sure that how these medications related to the outcomes in this study.